Christensenella minuta DSM 22607 is an anaerobe, Gram-negative, rod-shaped bacterium that was isolated from faeces from a healthy Japanese male.
Gram-negative rod-shaped anaerobe genome sequence 16S sequence Bacteria| @ref 20215 |
|
|
| Domain Bacteria |
| Phylum Bacillota |
| Class Clostridia |
| Order Eubacteriales |
| Family Christensenellaceae |
| Genus Christensenella |
| Species Christensenella minuta |
| Full scientific name Christensenella minuta Morotomi et al. 2012 |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 21228 | WILKINS-CHALGREN ANAEROBE BROTH (N2/CO2) (DSMZ Medium 339a) | Medium recipe at MediaDive | Name: WILKINS-CHALGREN ANAEROBE BROTH (N2/CO2) (DSMZ Medium 339a) Composition: dehydrated Wilkins-Chalgren medium 33.0 g/l D-Glucose 5.0 g/l L-Cysteine HCl 0.3 g/l Sodium resazurin 0.0005 g/l Distilled water | ||
| 21228 | RCM MEDIUM (N2/CO2) (DSMZ Medium 634c) | Medium recipe at MediaDive | Name: RCM MEDIUM (N2/CO2) (DSMZ Medium 634c) Composition: dehydrated RCM medium 38.0 g/l Sodium carbonate 1.0 g/l Sodium resazurin 0.0005 g/l Distilled water | ||
| 21228 | CHOPPED MEDIUM (N2/CO2) (DSMZ Medium 78b) | Medium recipe at MediaDive | Name: CHOPPED MEDIUM (N2/CO2) (DSMZ Medium 78b) Composition: Ground beef 487.805 g/l Casitone 29.2683 g/l K2HPO4 4.87805 g/l Yeast extract 4.87805 g/l L-Cysteine HCl x H2O 0.487805 g/l Ethanol 0.00926829 g/l Haemin 0.00487805 g/l Sodium resazurin 0.000487805 g/l Vitamin K3 4.87805e-05 g/l NaOH Distilled water Vitamin K1 Water |
| 29932 | Spore formationno |
| @ref | Salt | Growth | Tested relation | Concentration | |
|---|---|---|---|---|---|
| 29932 | NaCl | positive | growth | <5 % |
| @ref | pathway | enzyme coverage | annotated reactions | external links | |
|---|---|---|---|---|---|
| 66794 | adipate degradation | 100 | 2 of 2 | ||
| 66794 | gluconeogenesis | 100 | 8 of 8 | ||
| 66794 | L-lactaldehyde degradation | 100 | 3 of 3 | ||
| 66794 | ribulose monophosphate pathway | 100 | 2 of 2 | ||
| 66794 | starch degradation | 100 | 10 of 10 | ||
| 66794 | palmitate biosynthesis | 100 | 22 of 22 | ||
| 66794 | coenzyme A metabolism | 100 | 4 of 4 | ||
| 66794 | CDP-diacylglycerol biosynthesis | 100 | 2 of 2 | ||
| 66794 | UDP-GlcNAc biosynthesis | 100 | 3 of 3 | ||
| 66794 | formaldehyde oxidation | 100 | 3 of 3 | ||
| 66794 | folate polyglutamylation | 100 | 1 of 1 | ||
| 66794 | suberin monomers biosynthesis | 100 | 2 of 2 | ||
| 66794 | cis-vaccenate biosynthesis | 100 | 2 of 2 | ||
| 66794 | anapleurotic synthesis of oxalacetate | 100 | 1 of 1 | ||
| 66794 | C4 and CAM-carbon fixation | 100 | 8 of 8 | ||
| 66794 | pentose phosphate pathway | 90.91 | 10 of 11 | ||
| 66794 | chorismate metabolism | 88.89 | 8 of 9 | ||
| 66794 | valine metabolism | 88.89 | 8 of 9 | ||
| 66794 | degradation of sugar alcohols | 87.5 | 14 of 16 | ||
| 66794 | reductive acetyl coenzyme A pathway | 85.71 | 6 of 7 | ||
| 66794 | propanol degradation | 85.71 | 6 of 7 | ||
| 66794 | phenylalanine metabolism | 84.62 | 11 of 13 | ||
| 66794 | glutamate and glutamine metabolism | 82.14 | 23 of 28 | ||
| 66794 | Entner Doudoroff pathway | 80 | 8 of 10 | ||
| 66794 | peptidoglycan biosynthesis | 80 | 12 of 15 | ||
| 66794 | threonine metabolism | 80 | 8 of 10 | ||
| 66794 | photosynthesis | 78.57 | 11 of 14 | ||
| 66794 | CO2 fixation in Crenarchaeota | 77.78 | 7 of 9 | ||
| 66794 | d-mannose degradation | 77.78 | 7 of 9 | ||
| 66794 | ketogluconate metabolism | 75 | 6 of 8 | ||
| 66794 | ppGpp biosynthesis | 75 | 3 of 4 | ||
| 66794 | isoleucine metabolism | 75 | 6 of 8 | ||
| 66794 | glycogen biosynthesis | 75 | 3 of 4 | ||
| 66794 | CMP-KDO biosynthesis | 75 | 3 of 4 | ||
| 66794 | butanoate fermentation | 75 | 3 of 4 | ||
| 66794 | purine metabolism | 73.4 | 69 of 94 | ||
| 66794 | citric acid cycle | 71.43 | 10 of 14 | ||
| 66794 | degradation of pentoses | 71.43 | 20 of 28 | ||
| 66794 | glycolysis | 70.59 | 12 of 17 | ||
| 66794 | alanine metabolism | 68.97 | 20 of 29 | ||
| 66794 | methane metabolism | 66.67 | 2 of 3 | ||
| 66794 | serine metabolism | 66.67 | 6 of 9 | ||
| 66794 | cyanate degradation | 66.67 | 2 of 3 | ||
| 66794 | degradation of hexoses | 66.67 | 12 of 18 | ||
| 66794 | aspartate and asparagine metabolism | 66.67 | 6 of 9 | ||
| 66794 | octane oxidation | 66.67 | 2 of 3 | ||
| 66794 | acetoin degradation | 66.67 | 2 of 3 | ||
| 66794 | NAD metabolism | 66.67 | 12 of 18 | ||
| 66794 | methionine metabolism | 65.38 | 17 of 26 | ||
| 66794 | pyrimidine metabolism | 64.44 | 29 of 45 | ||
| 66794 | tetrahydrofolate metabolism | 64.29 | 9 of 14 | ||
| 66794 | 6-hydroxymethyl-dihydropterin diphosphate biosynthesis | 62.5 | 5 of 8 | ||
| 66794 | dTDPLrhamnose biosynthesis | 62.5 | 5 of 8 | ||
| 66794 | glycogen metabolism | 60 | 3 of 5 | ||
| 66794 | 4-hydroxyphenylacetate degradation | 60 | 6 of 10 | ||
| 66794 | cellulose degradation | 60 | 3 of 5 | ||
| 66794 | hydrogen production | 60 | 3 of 5 | ||
| 66794 | propionate fermentation | 60 | 6 of 10 | ||
| 66794 | glycine betaine biosynthesis | 60 | 3 of 5 | ||
| 66794 | lipoate biosynthesis | 60 | 3 of 5 | ||
| 66794 | tryptophan metabolism | 57.89 | 22 of 38 | ||
| 66794 | oxidative phosphorylation | 57.14 | 52 of 91 | ||
| 66794 | cysteine metabolism | 55.56 | 10 of 18 | ||
| 66794 | non-pathway related | 55.26 | 21 of 38 | ||
| 66794 | urea cycle | 53.85 | 7 of 13 | ||
| 66794 | leucine metabolism | 53.85 | 7 of 13 | ||
| 66794 | histidine metabolism | 51.72 | 15 of 29 | ||
| 66794 | arginine metabolism | 50 | 12 of 24 | ||
| 66794 | glycolate and glyoxylate degradation | 50 | 3 of 6 | ||
| 66794 | toluene degradation | 50 | 2 of 4 | ||
| 66794 | kanosamine biosynthesis II | 50 | 1 of 2 | ||
| 66794 | sulfopterin metabolism | 50 | 2 of 4 | ||
| 66794 | ethanol fermentation | 50 | 1 of 2 | ||
| 66794 | glycine metabolism | 50 | 5 of 10 | ||
| 66794 | phenylmercury acetate degradation | 50 | 1 of 2 | ||
| 66794 | acetate fermentation | 50 | 2 of 4 | ||
| 66794 | selenocysteine biosynthesis | 50 | 3 of 6 | ||
| 66794 | lysine metabolism | 50 | 21 of 42 | ||
| 66794 | metabolism of disaccharids | 45.45 | 5 of 11 | ||
| 66794 | proline metabolism | 45.45 | 5 of 11 | ||
| 66794 | tyrosine metabolism | 42.86 | 6 of 14 | ||
| 66794 | cardiolipin biosynthesis | 42.86 | 3 of 7 | ||
| 66794 | ubiquinone biosynthesis | 42.86 | 3 of 7 | ||
| 66794 | isoprenoid biosynthesis | 42.31 | 11 of 26 | ||
| 66794 | degradation of aromatic, nitrogen containing compounds | 41.67 | 5 of 12 | ||
| 66794 | ascorbate metabolism | 40.91 | 9 of 22 | ||
| 66794 | methylglyoxal degradation | 40 | 2 of 5 | ||
| 66794 | metabolism of amino sugars and derivatives | 40 | 2 of 5 | ||
| 66794 | bacilysin biosynthesis | 40 | 2 of 5 | ||
| 66794 | factor 420 biosynthesis | 40 | 2 of 5 | ||
| 66794 | flavin biosynthesis | 40 | 6 of 15 | ||
| 66794 | arachidonate biosynthesis | 40 | 2 of 5 | ||
| 66794 | myo-inositol biosynthesis | 40 | 4 of 10 | ||
| 66794 | lipid metabolism | 38.71 | 12 of 31 | ||
| 66794 | vitamin B1 metabolism | 38.46 | 5 of 13 | ||
| 66794 | d-xylose degradation | 36.36 | 4 of 11 | ||
| 66794 | degradation of sugar acids | 36 | 9 of 25 | ||
| 66794 | polyamine pathway | 34.78 | 8 of 23 | ||
| 66794 | lipid A biosynthesis | 33.33 | 3 of 9 | ||
| 66794 | IAA biosynthesis | 33.33 | 1 of 3 | ||
| 66794 | sphingosine metabolism | 33.33 | 2 of 6 | ||
| 66794 | acetyl CoA biosynthesis | 33.33 | 1 of 3 | ||
| 66794 | molybdenum cofactor biosynthesis | 33.33 | 3 of 9 | ||
| 66794 | nitrate assimilation | 33.33 | 3 of 9 | ||
| 66794 | androgen and estrogen metabolism | 31.25 | 5 of 16 | ||
| 66794 | coenzyme M biosynthesis | 30 | 3 of 10 | ||
| 66794 | vitamin B12 metabolism | 29.41 | 10 of 34 | ||
| 66794 | benzoyl-CoA degradation | 28.57 | 2 of 7 | ||
| 66794 | lactate fermentation | 25 | 1 of 4 | ||
| 66794 | cyclohexanol degradation | 25 | 1 of 4 | ||
| 66794 | carnitine metabolism | 25 | 2 of 8 | ||
| 66794 | biotin biosynthesis | 25 | 1 of 4 | ||
| 66794 | phenol degradation | 25 | 5 of 20 | ||
| 66794 | sulfate reduction | 23.08 | 3 of 13 | ||
| 66794 | phosphatidylethanolamine bioynthesis | 23.08 | 3 of 13 | ||
| 66794 | arachidonic acid metabolism | 22.22 | 4 of 18 | ||
| 66794 | 4-hydroxymandelate degradation | 22.22 | 2 of 9 | ||
| 66794 | glutathione metabolism | 21.43 | 3 of 14 |
| Cat1 | Cat2 | Cat3 | |
|---|---|---|---|
| #Host | #Human | #Male | |
| #Host Body Product | #Gastrointestinal tract | #Feces (Stool) |
Global distribution of 16S sequence AB490809 (>99% sequence identity) for Christensenella from Microbeatlas ![]()
| @ref | Biosafety level | Biosafety level comment | |
|---|---|---|---|
| 21228 | 1 | Risk group (German classification) |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | ASM362875v1 assembly for Christensenella minuta DSM 22607 | complete | 626937 | 98 | ||||
| 67770 | ASM165270v1 assembly for Christensenella minuta DSM 22607 | contig | 626937 | 69.86 | ||||
| 67770 | ASM167885v1 assembly for Christensenella minuta DSM 22607 | scaffold | 626937 | 66.75 | ||||
| 67770 | ASM157142v1 assembly for Christensenella minuta DSM 22607 | scaffold | 626937 | 64.78 |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 21228 | Christensenella minuta gene for 16S rRNA, partial sequence | AB490809 | 1497 | 626937 |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125439 | spore_formation | BacteriaNetⓘ | yes | 77.20 | no |
| 125439 | motility | BacteriaNetⓘ | yes | 79.90 | no |
| 125439 | gram_stain | BacteriaNetⓘ | variable | 70.30 | no |
| 125439 | oxygen_tolerance | BacteriaNetⓘ | anaerobe | 99.20 | no |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125438 | gram-positive | gram-positiveⓘ | yes | 77.05 | no |
| 125438 | anaerobic | anaerobicⓘ | yes | 88.89 | yes |
| 125438 | aerobic | aerobicⓘ | no | 97.31 | yes |
| 125438 | spore-forming | spore-formingⓘ | no | 63.81 | no |
| 125438 | thermophilic | thermophileⓘ | no | 87.16 | no |
| 125438 | flagellated | motile2+ⓘ | no | 84.70 | yes |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Christensenella minuta protects and restores intestinal barrier in a colitis mouse model by regulating inflammation. | Kropp C, Tambosco K, Chadi S, Langella P, Claus SP, Martin R. | NPJ Biofilms Microbiomes | 10.1038/s41522-024-00540-6 | 2024 | ||
| Christensenella minuta, a new candidate next-generation probiotic: current evidence and future trajectories. | Ignatyeva O, Tolyneva D, Kovalyov A, Matkava L, Terekhov M, Kashtanova D, Zagainova A, Ivanov M, Yudin V, Makarov V, Keskinov A, Kraevoy S, Yudin S. | Front Microbiol | 10.3389/fmicb.2023.1241259 | 2023 | ||
| A Keystone Gut Bacterium Christensenella minuta-A Potential Biotherapeutic Agent for Obesity and Associated Metabolic Diseases. | Ang WS, Law JW, Letchumanan V, Hong KW, Wong SH, Ab Mutalib NS, Chan KG, Lee LH, Tan LT. | Foods | 10.3390/foods12132485 | 2023 | ||
| Non-lactic acid bacteria probiotics isolated from intestine or various circumstances. | Lee NK, Jang HJ, Paik HD. | Food Sci Biotechnol | 10.1007/s10068-024-01608-x | 2024 | ||
| Targeted Intervention Strategies for Maternal-Offspring Transmission of Christensenellaceae in Pigs via a Deep Learning Model. | Shen H, Ma X, Zhang L, Li H, Zheng J, Wu S, Zuo K, Yin Y, Wang J, Tan B. | Adv Sci (Weinh) | 10.1002/advs.202503411 | 2025 | ||
| Identifying a Novel Bile Salt Hydrolase from the Keystone Gut Bacterium Christensenella minuta. | Dejean G, Tudela H, Bruno L, Kissi D, Rawadi G, Claus SP. | Microorganisms | 10.3390/microorganisms9061252 | 2021 | ||
| Selection of a novel strain of Christensenella minuta as a future biotherapy for Crohn's disease. | Relizani K, Le Corf K, Kropp C, Martin-Rosique R, Kissi D, Dejean G, Bruno L, Martinez C, Rawadi G, Elustondo F, Mazier W, Claus SP. | Sci Rep | 10.1038/s41598-022-10015-3 | 2022 | ||
| The keystone gut species Christensenella minuta boosts gut microbial biomass and voluntary physical activity in mice. | Akbuga-Schon T, Suzuki TA, Jakob D, Vu DL, Waters JL, Ley RE. | mBio | 10.1128/mbio.02836-23 | 2024 | ||
| Genetics | Exploring the trimethylamine-degrading genes in the human gut microbiome. | Chen YR, Chen LD, Zheng LJ. | AMB Express | 10.1186/s13568-025-01902-9 | 2025 | |
| Enzymology | A New Strain of Christensenella minuta as a Potential Biotherapy for Obesity and Associated Metabolic Diseases. | Mazier W, Le Corf K, Martinez C, Tudela H, Kissi D, Kropp C, Coubard C, Soto M, Elustondo F, Rawadi G, Claus SP. | Cells | 10.3390/cells10040823 | 2021 | |
| Comprehensive Analysis of Allulose Production: A Review and Update. | Wang L, Cui Y, Lu Y, Zhao Z. | Foods | 10.3390/foods13162572 | 2024 | ||
| Genetics | Targeted isolation of Methanobrevibacter strains from fecal samples expands the cultivated human archaeome. | Duller S, Vrbancic S, Szydlowski L, Mahnert A, Blohs M, Predl M, Kumpitsch C, Zrim V, Hogenauer C, Kosciolek T, Schmitz RA, Eberhard A, Dragovan M, Schmidberger L, Zurabischvili T, Weinberger V, Moser AM, Kolb D, Pernitsch D, Mohammadzadeh R, Kuhnast T, Rattei T, Moissl-Eichinger C. | Nat Commun | 10.1038/s41467-024-52037-7 | 2024 | |
| Biocatalytic Synthesis of D-Allulose Using Novel D-Tagatose 3-Epimerase From Christensenella minuta. | Wang Y, Ravikumar Y, Zhang G, Yun J, Zhang Y, Parvez A, Qi X, Sun W. | Front Chem | 10.3389/fchem.2020.622325 | 2020 | ||
| The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health. | Waters JL, Ley RE. | BMC Biol | 10.1186/s12915-019-0699-4 | 2019 | ||
| Evaluating the anti-inflammatory and antioxidant efficacy of complementary and alternative medicines (CAM) used for management of inflammatory bowel disease: a comprehensive review. | Shin S, Chen S, Xie K, Duhun SA, Ortiz-Cerda T. | Redox Rep | 10.1080/13510002.2025.2471737 | 2025 | ||
| Probiotics in Intestinal Mucosal Healing: A New Therapy or an Old Friend? | Filidou E, Kolios G. | Pharmaceuticals (Basel) | 10.3390/ph14111181 | 2021 | ||
| The Plethora of Microbes with Anti-Inflammatory Activities. | Tsvetanova F. | Int J Mol Sci | 10.3390/ijms25052980 | 2024 | ||
| Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches. | Stofilova J, Kvakova M, Kamlarova A, Hijova E, Bertkova I, Gulasova Z. | Biomedicines | 10.3390/biomedicines10092236 | 2022 | ||
| Assessment of Gram- and Viability-Staining Methods for Quantifying Bacterial Community Dynamics Using Flow Cytometry. | Duquenoy A, Bellais S, Gasc C, Schwintner C, Dore J, Thomas V. | Front Microbiol | 10.3389/fmicb.2020.01469 | 2020 | ||
| Metabolism | Syntrophy via Interspecies H2 Transfer between Christensenella and Methanobrevibacter Underlies Their Global Cooccurrence in the Human Gut. | Ruaud A, Esquivel-Elizondo S, de la Cuesta-Zuluaga J, Waters JL, Angenent LT, Youngblut ND, Ley RE. | mBio | 10.1128/mbio.03235-19 | 2020 | |
| Phylogeny | Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease. | Ravichandar JD, Rutherford E, Chow CT, Han A, Yamamoto ML, Narayan N, Kaplan GG, Beck PL, Claesson MJ, Dabbagh K, Iwai S, DeSantis TZ. | Front Microbiol | 10.3389/fmicb.2022.961020 | 2022 | |
| The Characterization of a Novel D-allulose 3-Epimerase from Blautia produca and Its Application in D-allulose Production. | Tang X, An Y, Iqbal MW, Cong H, Zhang G, Zhang Y, Ravikumar Y, Zabed HM, Zhao M, Zhou H, Qi X. | Foods | 10.3390/foods11203225 | 2022 | ||
| StrainSelect: A novel microbiome reference database that disambiguates all bacterial strains, genome assemblies and extant cultures worldwide. | DeSantis TZ, Cardona C, Narayan NR, Viswanatham S, Ravichandar D, Wee B, Chow CE, Iwai S. | Heliyon | 10.1016/j.heliyon.2023.e13314 | 2023 | ||
| Alpha-tocopheryl quinone attenuates liver fibrosis through enriching Christensenella minuta and modulating bile acids metabolism via gut-liver axis. | Chen J, Zhang L, Chen Y, Yan Y, Lu C. | Phytomedicine | 10.1016/j.phymed.2025.157108 | 2025 | ||
| Effects of a bacillus-based biological modulator on Salmonella Heidelberg contamination and cecal microbiota in chickens. | Richter JL, Kaefer BGG, Dos Santos EAR, Tadielo LE, Schmiedt JA, Fiaga DAM, Barcellos VC, Alberton GC, Dos Santos Bersot L. | Res Vet Sci | 10.1016/j.rvsc.2025.105914 | 2025 | ||
| Gut Microbiome Interventions: From Dysbiosis to Next-Generation Probiotics (NGPs) for Disease Management. | Gupta MK, Srivastava R. | Probiotics Antimicrob Proteins | 10.1007/s12602-025-10582-7 | 2025 | ||
| Leonurine restrains granulosa cell ferroptosis through SLC7A11/GPX4 axis to promote the treatment of polycystic ovary syndrome. | Huang X, Geng H, Liang C, Xiong X, Du X, Zhuan Q, Liu Z, Meng L, Zhou D, Zhang L, Fu X, Qi X, Hou Y. | Free Radic Biol Med | 10.1016/j.freeradbiomed.2024.11.021 | 2025 | ||
| Christensenella minuta mitigates behavioral and cardiometabolic hallmarks of social defeat stress. | Agusti A, Molina-Mendoza GV, Tamayo M, Rossini V, Cenit MC, Frances-Cuesta C, Tolosa-Enguis V, Gomez Del Pulgar EM, Flor-Duro A, Sanz Y. | Biomed Pharmacother | 10.1016/j.biopha.2024.117377 | 2024 | ||
| Genetics | Complete genome sequence of two Christensenella minuta strains CIP 112228 and CIP 112229, isolated from human fecal samples. | Bouchier C, Touak G, Rei D, Clermont D. | Microbiol Resour Announc | 10.1128/mra.00766-24 | 2024 | |
| Metabolism | 3-O-acylated bile acids: disrupters or harmonizers of metabolism? | Chen R, Chen X, Gao J. | Trends Mol Med | 10.1016/j.molmed.2024.06.003 | 2025 | |
| Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients. | Chen J, Levy A, Tian AL, Huang X, Cai G, Fidelle M, Rauber C, Ly P, Pizzato E, Sitterle L, Piccinno G, Liu P, Durand S, Mao M, Zhao L, Iebba V, Felchle H, Mallard de La Varende AL, Fischer JC, Thomas S, Greten TF, Jones JC, Monge C, Demaria S, Formenti S, Belluomini L, Dionisi V, Massard C, Blanchard P, Robert C, Quevrin C, Lopes E, Clemenson C, Mondini M, Meziani L, Zhan Y, Zeng C, Cai Q, Morel D, Sun R, Laurent PA, Mangoni M, Di Cataldo V, Arilli C, Trommer M, Wegen S, Neppl S, Riechelmann RP, Camandaroba MP, Neto ES, Fournier PE, Segata N, Holicek P, Galluzzi L, Buque A, Alves Costa Silva C, Derosa L, Kroemer G, Chen C, Zitvogel L, Deutsch E. | Cancer Cell | 10.1016/j.ccell.2025.02.010 | 2025 | ||
| Gut commensal Christensenella minuta modulates host metabolism via acylated secondary bile acids. | Liu C, Du MX, Xie LS, Wang WZ, Chen BS, Yun CY, Sun XW, Luo X, Jiang Y, Wang K, Jiang MZ, Qiao SS, Sun M, Cui BJ, Huang HJ, Qu SP, Li CK, Wu D, Wang LS, Jiang C, Liu HW, Liu SJ. | Nat Microbiol | 10.1038/s41564-023-01570-0 | 2024 | ||
| Unveiling roles of beneficial gut bacteria and optimal diets for health. | Kumar S, Mukherjee R, Gaur P, Leal E, Lyu X, Ahmad S, Puri P, Chang CM, Raj VS, Pandey RP. | Front Microbiol | 10.3389/fmicb.2025.1527755 | 2025 | ||
| Development of live biotherapeutic products: a position statement of Asia-Pacific Microbiota Consortium. | Tseng CH, Wong S, Yu J, Lee YY, Terauchi J, Lai HC, Luo JC, Kao CY, Yu SL, Liou JM, Wu DC, Hou MC, Wu MS, Wu JJ, Sung JJY, El-Omar EM, Wu CY. | Gut | 10.1136/gutjnl-2024-334501 | 2025 | ||
| Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens. | Villanueva-Millan MJ, Leite G, Mathur R, Rezaie A, Fajardo CM, de Freitas Germano J, Morales W, Sanchez M, Rivera I, Parodi G, Weitsman S, Rashid M, Hosseini A, Brimberry D, Barlow GM, Pimentel M. | Dig Dis Sci | 10.1007/s10620-025-09156-y | 2025 | ||
| Christensenella minuta Alleviates Acetaminophen-Induced Hepatotoxicity by Regulating Phenylalanine Metabolism. | Yao T, Fu L, Wu Y, Li L. | Nutrients | 10.3390/nu16142314 | 2024 | ||
| The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies. | Yaghmaei H, Bahanesteh A, Soltanipur M, Takaloo S, Rezaei M, Siadat SD. | Int J Hepatol | 10.1155/2024/4183880 | 2024 | ||
| Faecal pharmacokinetics, microbiome, and bile acid changes in healthy subjects given intravenous followed by oral omadacycline; a Phase 1 clinical trial. | Jo J, Carlson TJ, Hu C, Williamson JC, Belin YT, Horvath TD, Haidacher SJ, Basseres E, Begum K, Alam MJ, Garey KW. | J Antimicrob Chemother | 10.1093/jac/dkaf278 | 2025 | ||
| Effects of Levilactobacillus brevis GKEX supplementation on exercise performance and fatigue resistance in mice. | Lin TC, Chen CC, Tsai YS, Lin SW, Huang CC, Hsu YJ. | Front Nutr | 10.3389/fnut.2025.1625645 | 2025 | ||
| Christensenella minuta interacts with multiple gut bacteria. | Xu C, Jiang H, Feng LJ, Jiang MZ, Wang YL, Liu SJ. | Front Microbiol | 10.3389/fmicb.2024.1301073 | 2024 | ||
| Bacteremia caused by Desulfovibrio desulfuricans with the intestinal tract as the portal of entry: two case reports and a literature review. | Yamaizumi K, Kyotani M, Kenzaka T. | BMC Infect Dis | 10.1186/s12879-024-09623-3 | 2024 | ||
| Metabolism | Novel Approaches in Glucose and Lipid Metabolism Disorder Therapy: Targeting the Gut Microbiota-Bile Acid Axis. | Jiang J, Zhang H, Hussain M, Abdullah, Feng F, Guan R, Zhong H. | Biology (Basel) | 10.3390/biology14070802 | 2025 | |
| Spatial heterogeneity determines the gastrointestinal microbiome signatures in Pekin ducks. | Zhao H, Hu Z, Ru J, Wang Z, Wei J, Zhou W, Hou S, Zhang Y, Wang X. | Poult Sci | 10.1016/j.psj.2025.105994 | 2025 | ||
| Oxidative degradation of alpha-tocopherol by reactive oxygen species, identifying products, and product anticancer activity. | Ali HM, Attia MH, Mamdouh W, Rashed EN, Ali IH. | BMC Chem | 10.1186/s13065-025-01665-1 | 2025 | ||
| Pathogenicity | Gut Microbiome dysbiosis and immune activation correlate with somatic and neuropsychiatric symptoms in COVID-19 patients. | Scalzo PL, Marshall AG, Soriano S, Curry K, Dulay M, Hodics T, Quigley EMM, Treangen TJ, Piskorz MM, Villapol S. | J Transl Med | 10.1186/s12967-025-06348-y | 2025 | |
| Does gut microbiota dysbiosis impact the metabolic alterations of hydrogen sulfide and lanthionine in patients with chronic kidney disease? | Garcia-Martinez Y, Alexandrova E, Iebba V, Ferravante C, Spinelli M, Franci G, Amoresano A, Weisz A, Trepiccione F, Borriello M, Ingrosso D, Perna AF. | BMC Microbiol | 10.1186/s12866-024-03590-0 | 2024 | ||
| Metabolism | High rejection rate of polysaccharides by microfiltration benefits Christensenella minuta and acetic acid production in an anaerobic membrane bioreactor for sludge fermentation. | Gao X, Zhang Q, Zhu H. | Bioresour Technol | 10.1016/j.biortech.2019.03.015 | 2019 | |
| The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives. | Vallianou NG, Kounatidis D, Tsilingiris D, Panagopoulos F, Christodoulatos GS, Evangelopoulos A, Karampela I, Dalamaga M. | Int J Mol Sci | 10.3390/ijms24076755 | 2023 | ||
| Integrated multi-omics landscape of non-small cell lung cancer with distant metastasis. | He T, Jiang T, Sun X, Yang F, Zhang D, Yao S, Liao J, Wu X. | Front Immunol | 10.3389/fimmu.2025.1560724 | 2025 | ||
| Pathogenicity | Gut health predictive indices linking gut microbiota dysbiosis with healthy state, mild gut discomfort, and inflammatory bowel disease phenotypes using gut microbiome profiling. | Phan J, Jain S, Nijkamp JF, Sasidharan R, Agarwal A, Bird JK, Spooren A, Wittwer Schegg J, Ver Loren van Themaat E, Mak TN. | Microbiol Spectr | 10.1128/spectrum.00271-25 | 2025 | |
| Pathogenicity | Effects of Christensenella minuta lipopolysaccharide on RAW 264.7 macrophages activation. | Yang Y, Gu H, Sun Q, Wang J. | Microb Pathog | 10.1016/j.micpath.2018.10.005 | 2018 | |
| Targeted Gut Microbiota Modulation Enhances Levodopa Bioavailability and Motor Recovery in MPTP Parkinson's Disease Models. | Ai P, Xu S, Yuan Y, Xu Z, He X, Mo C, Zhang Y, Yang X, Xiao Q. | Int J Mol Sci | 10.3390/ijms26115282 | 2025 | ||
| Association between seizure reduction during ketogenic diet treatment of epilepsy and changes in circulatory metabolites and gut microbiota composition. | Dahlin M, Wheelock CE, Prast-Nielsen S. | EBioMedicine | 10.1016/j.ebiom.2024.105400 | 2024 | ||
| Enzymology | First report of human infection by Christensenella minuta, a gram-negative, strickly anaerobic rod that inhabits the human intestine. | Alonso BL, Irigoyen von Sierakowski A, Saez Nieto JA, Rosel AB. | Anaerobe | 10.1016/j.anaerobe.2017.03.007 | 2017 | |
| Bile Acids and Type 2 Diabetes: Roles in Glucose Homeostasis and Therapeutic Opportunities. | Lin Y, Hu C, Wang S, Lin H. | Metabolites | 10.3390/metabo15060401 | 2025 | ||
| Microbiome and metabolome explain the high-fat diet-induced diabetes development and diabetes resistance in Guizhou mini-pigs. | Wu Y, Mo J, Wang Q, Li J, Wei J, Zhang N, Dong Y, Zhu X, Lu T, Huang S. | Front Microbiol | 10.3389/fmicb.2025.1555069 | 2025 | ||
| Christensenella strain resources, genomic/metabolomic profiling, and association with host at species level. | Sun XW, Huang HJ, Wang XM, Wei RQ, Niu HY, Chen HY, Luo M, Abdugheni R, Wang YL, Liu FL, Jiang H, Liu C, Liu SJ. | Gut Microbes | 10.1080/19490976.2024.2347725 | 2024 | ||
| Probiotic-induced enrichment of Adlercreutzia equolifaciens increases gut microbiome wellness index and maps to lower host blood glucose levels. | Zhang Z, Yang Z, Lin S, Jiang S, Zhou X, Li J, Lu W, Zhang J. | Gut Microbes | 10.1080/19490976.2025.2520407 | 2025 | ||
| Gut Bacteria in Alcohol-Associated Liver Disease. | Yang Y, Schnabl B. | Clin Liver Dis | 10.1016/j.cld.2024.06.008 | 2024 | ||
| Associations between the rumen microbiota and carcass merit and meat quality in beef cattle. | Holman DB, Gzyl KE, Scott H, Cara Service, Prieto N, Lopez-Campos O. | Appl Microbiol Biotechnol | 10.1007/s00253-024-13126-1 | 2024 | ||
| Multiomics Revealed the Multi-Dimensional Effects of Late Sleep on Gut Microbiota and Metabolites in Children in Northwest China. | Xiang X, Chen J, Zhu M, Gao H, Liu X, Wang Q, Wang Q. | Nutrients | 10.3390/nu15204315 | 2023 | ||
| Research status and development trends of probiotics in clinical applications. | Li Y, Yao Y, Zhang Z, Gan Y. | Front Nutr | 10.3389/fnut.2025.1650883 | 2025 | ||
| Christensenella timonensis, a new bacterial species isolated from the human gut. | Ndongo S, Dubourg G, Khelaifia S, Fournier PE, Raoult D. | New Microbes New Infect | 10.1016/j.nmni.2016.05.010 | 2016 | ||
| Different intestinal ecological niches drive the divergent evolution of probiotics in the gut. | Han Z, Huang D, Liu X, Ma W, Cui W, Jiang S, Zhen D, Zhang J. | ISME Commun | 10.1093/ismeco/ycaf023 | 2025 | ||
| Phylogeny | Metagenomic Insights into the Anti-Obesity Effect of a Polysaccharide from Saccharina japonica. | Song Y, Lu D, Wang H, Zhou Z, Luo X, Ma M, Ke S, Wang H, Yu Y, Wei B. | Foods | 10.3390/foods12030665 | 2023 | |
| Transcriptome | Gut microbiota predict retinopathy in patients with diabetes: A longitudinal cohort study. | Qin X, Sun J, Chen S, Xu Y, Lu L, Lu M, Li J, Ma Y, Lou F, Zou H. | Appl Microbiol Biotechnol | 10.1007/s00253-024-13316-x | 2024 | |
| Phylogeny | In Search of Healthy Ageing: A Microbiome-Based Precision Nutrition Approach for Type 2 Diabetes Prevention. | Gonzalez A, Fullaondo A, Odriozola A. | Nutrients | 10.3390/nu17111877 | 2025 | |
| Phylogeny | Analysis of Gut Microbiota in Patients with Parkinson's Disease. | Petrov VA, Saltykova IV, Zhukova IA, Alifirova VM, Zhukova NG, Dorofeeva YB, Tyakht AV, Kovarsky BA, Alekseev DG, Kostryukova ES, Mironova YS, Izhboldina OP, Nikitina MA, Perevozchikova TV, Fait EA, Babenko VV, Vakhitova MT, Govorun VM, Sazonov AE. | Bull Exp Biol Med | 10.1007/s10517-017-3700-7 | 2017 | |
| Comparative Analysis of Fecal Microbiota Composition Between Rheumatoid Arthritis and Osteoarthritis Patients. | Lee JY, Mannaa M, Kim Y, Kim J, Kim GT, Seo YS. | Genes (Basel) | 10.3390/genes10100748 | 2019 | ||
| Effects of High-Concentrate-Induced SARA on Antioxidant Capacity, Immune Levels and Rumen Microbiota and Function in Goats. | Fan S, Zheng M, Ren A, Mao H, Long D, Yang L. | Animals (Basel) | 10.3390/ani14020263 | 2024 | ||
| Single, but not mixed dietary fibers suppress body weight gain and adiposity in high fat-fed mice. | Shallangwa SM, Ross AW, Morgan PJ. | Front Microbiol | 10.3389/fmicb.2025.1544433 | 2025 | ||
| Preclinical Assessment of Living Therapeutic Materials: State-of-Art and Challenges. | Desai K, Mekontso J, Deshpande K, Trujillo S. | ACS Biomater Sci Eng | 10.1021/acsbiomaterials.5c00247 | 2025 | ||
| Pathogenicity | Effect of chronic low-dose treatment with chitooligosaccharides on microbial dysbiosis and inflammation associated chronic ulcerative colitis in Balb/c mice. | Rajesh KM, Kinra M, Ranadive N, Pawaskar GM, Mudgal J, Raval R. | Naunyn Schmiedebergs Arch Pharmacol | 10.1007/s00210-023-02710-3 | 2024 | |
| Effects of Coenzyme Q10 on the Biomarkers (Hydrogen, Methane, SCFA and TMA) and Composition of the Gut Microbiome in Rats. | Ivanova AY, Shirokov IV, Toshchakov SV, Kozlova AD, Obolenskaya ON, Mariasina SS, Ivlev VA, Gartseev IB, Medvedev OS. | Pharmaceuticals (Basel) | 10.3390/ph16050686 | 2023 | ||
| Effects of Glucosinolate-Enriched Red Radish (Raphanus sativus) on In Vitro Models of Intestinal Microbiota and Metabolic Syndrome-Related Functionalities. | Roses C, Garcia-Ibanez P, Agudelo A, Viadel B, Tomas-Cobos L, Gallego E, Carvajal M, Milagro FI, Barcelo A. | ACS Omega | 10.1021/acsomega.2c08128 | 2023 | ||
| Characteristics of Gut Microbiota and Fecal Metabolites in Patients with Colorectal Cancer-Associated Iron Deficiency Anemia. | Zhang Q, Wu W, Guo F, Li J, Jin Y, Cai G, Yang Y. | Microorganisms | 10.3390/microorganisms12071319 | 2024 | ||
| Effects of prebiotics from diverse sources on dysbiotic gut microbiota associated to western diet: Insights from the human Mucosal ARtificial COLon (M-ARCOL). | Uriot O, Defois-Fraysse C, Couturier I, Deschamps C, Durif C, Chaudemanche C, Dreux-Zigha A, Blanquet-Diot S. | Curr Res Food Sci | 10.1016/j.crfs.2024.100968 | 2025 | ||
| Insect live larvae as a new nutritional model in duck: effects on gut health. | Colombino E, Gariglio M, Biasato I, Ferrocino I, Pozzo S, Fragola E, Battisti E, Zanet S, Ferroglio E, Capucchio MT, Schiavone A. | Anim Microbiome | 10.1186/s42523-024-00316-5 | 2024 | ||
| Gut microbiota dysbiosis in inflammatory bowel disease: interaction with intestinal barriers and microbiota-targeted treatment options. | Xie H, Yu S, Tang M, Xun Y, Shen Q, Wu G. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1608025 | 2025 | ||
| Characterization and Safety Evaluation of Autoclaved Gut Commensal Parabacteroides goldsteinii RV-01. | Lin TL, Chen WJ, Hung CM, Wong YL, Lu CC, Lai HC. | Int J Mol Sci | 10.3390/ijms252312660 | 2024 | ||
| Characteristics of putative keystones in the healthy adult human gut microbiota as determined by correlation network analysis. | Bauchinger F, Seki D, Berry D. | Front Microbiol | 10.3389/fmicb.2024.1454634 | 2024 | ||
| In vitro Inoculation of Fresh or Frozen Rumen Fluid Distinguishes Contrasting Microbial Communities and Fermentation Induced by Increasing Forage to Concentrate Ratio. | Ma ZY, Zhou JW, Yi SY, Wang M, Tan ZL. | Front Nutr | 10.3389/fnut.2021.772645 | 2021 | ||
| Vitamin C Supplementation in Healthy Individuals Leads to Shifts of Bacterial Populations in the Gut-A Pilot Study. | Otten AT, Bourgonje AR, Peters V, Alizadeh BZ, Dijkstra G, Harmsen HJM. | Antioxidants (Basel) | 10.3390/antiox10081278 | 2021 | ||
| Gut Microbiota and Metabolic Alterations Associated with Heart Failure and Coronary Artery Disease. | Yafarova AA, Dementeva EV, Zlobovskaya OA, Sheptulina AF, Lopatukhina EV, Timofeev YS, Glazunova EV, Lyundup AV, Doludin YV, Kiselev AR, Shipulin GA, Makarov VV, Drapkina OM, Yudin SM. | Int J Mol Sci | 10.3390/ijms252011295 | 2024 | ||
| Clostridioides difficile and neurological disorders: New perspectives. | Biazzo M, Allegra M, Deidda G. | Front Neurosci | 10.3389/fnins.2022.946601 | 2022 | ||
| Effects of ethnicity and geography on the fecal microbiota and dietary habits of Tibeto-Burman hill tribes in Northern Thailand. | Seetaraso T, Gruneck L, Jinatham V, Kantakat S, Albert ML, Therdtatha P, Inta A, Srikummool M, Kampuansai J, Popluechai S. | PLoS One | 10.1371/journal.pone.0332108 | 2025 | ||
| Exploring Next Generation Probiotics for Metabolic and Microbiota Dysbiosis Linked to Xenobiotic Exposure: Holistic Approach. | Torres-Sanchez A, Ruiz-Rodriguez A, Ortiz P, Moreno MA, Ampatzoglou A, Gruszecka-Kosowska A, Monteoliva-Sanchez M, Aguilera M. | Int J Mol Sci | 10.3390/ijms232112917 | 2022 | ||
| Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis. | Yang Y, Zheng X, Wang Y, Tan X, Zou H, Feng S, Zhang H, Zhang Z, He J, Cui B, Zhang X, Wu Z, Dong M, Cheng W, Tao S, Wei H. | Front Immunol | 10.3389/fimmu.2022.836542 | 2022 | ||
| Genetics | The gut microbiome as a potential source of non-invasive biomarkers of chronic obstructive pulmonary disease. | Li N, Yi X, Chen C, Dai Z, Deng Z, Pu J, Zhou Y, Li B, Wang Z, Ran P. | Front Microbiol | 10.3389/fmicb.2023.1173614 | 2023 | |
| Microbiota-produced immune regulatory bile acid metabolites control central nervous system autoimmunity. | Antonini Cencicchio M, Montini F, Palmieri V, Massimino L, Lo Conte M, Finardi A, Mandelli A, Asnicar F, Pavlovic R, Drago D, Ungaro F, Andolfo A, Segata N, Martinelli V, Furlan R, Falcone M. | Cell Rep Med | 10.1016/j.xcrm.2025.102028 | 2025 | ||
| Characterization of the gut microbiota and fecal and blood metabolomes under various factors in urban children from Northwest China. | Yang Y, Chen J, Gao H, Cui M, Zhu M, Xiang X, Wang Q. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1374544 | 2024 | ||
| Genetics | Uncovering new Firmicutes species in vertebrate hosts through metagenome-assembled genomes with potential for sporulation. | Machado DT, Dias BdC, Cayo R, Gales AC, Marques de Carvalho F, Vasconcelos ATR. | Microbiol Spectr | 10.1128/spectrum.02113-24 | 2024 | |
| Microbiome features associated with performance measures in athletic and non-athletic individuals: A case-control study. | Huminska-Lisowska K, Zielinska K, Mieszkowski J, Michalowska-Sawczyn M, Cieszczyk P, Labaj PP, Wasag B, Fraczek B, Grzywacz A, Kochanowicz A, Kosciolek T. | PLoS One | 10.1371/journal.pone.0297858 | 2024 | ||
| Effects of Black Soldier Fly Larvae (Hermetia illucens Larvae) Meal on the Production Performance and Cecal Microbiota of Hens. | Yan Y, Zhang J, Chen X, Wang Z. | Vet Sci | 10.3390/vetsci10050364 | 2023 | ||
| Pathogenicity | Microbial-Based Bioactive Compounds to Alleviate Inflammation in Obesity. | Apalowo OE, Adegoye GA, Obuotor TM. | Curr Issues Mol Biol | 10.3390/cimb46030119 | 2024 | |
| Inclusion of up to 20% Black Soldier Fly larvae meal in broiler chicken diet has a minor effect on caecal microbiota. | de Souza Vilela J, Kheravii SK, Sharma Bajagai Y, Kolakshyapati M, Zimazile Sibanda T, Wu SB, Andrew NR, Ruhnke I. | PeerJ | 10.7717/peerj.15857 | 2023 | ||
| Next-generation probiotics - do they open new therapeutic strategies for cancer patients? | Kazmierczak-Siedlecka K, Skonieczna-Zydecka K, Hupp T, Duchnowska R, Marek-Trzonkowska N, Polom K. | Gut Microbes | 10.1080/19490976.2022.2035659 | 2022 | ||
| Resident gut microbiota community determines the efficacy of soluble fiber in reducing adiposity. | Shallangwa SM, Ross AW, Walker AW, Morgan PJ. | Front Microbiol | 10.3389/fmicb.2024.1392016 | 2024 | ||
| Dysbiotic Gut Bacteria in Obesity: An Overview of the Metabolic Mechanisms and Therapeutic Perspectives of Next-Generation Probiotics. | Breton J, Galmiche M, Dechelotte P. | Microorganisms | 10.3390/microorganisms10020452 | 2022 | ||
| Microbiome Shift, Diversity, and Overabundance of Opportunistic Pathogens in Bovine Digital Dermatitis Revealed by 16S rRNA Amplicon Sequencing. | Espiritu HM, Mamuad LL, Kim SH, Jin SJ, Lee SS, Kwon SW, Cho YI. | Animals (Basel) | 10.3390/ani10101798 | 2020 | ||
| Proteomic and metabolomic profiling of extracellular vesicles produced by human gut archaea | Weinberger V, Darnhofer B, Thapa H, Mertelj P, Stentz R, Jones E, Grabmann G, Mohammadzadeh R, Shinde T, Karner C, Ober J, Juodeikis R, Pernitsch D, Hingerl K, Zurabishvili T, Kumpitsch C, Kuehnast T, Rinner B, Strohmaier H, Kolb D, Gotts K, Weichhart T, Kocher T, Kofeler H, Carding S, Schild S, Moissl-Eichinger C. | Nat Commun | 2025 | |||
| Microbes as medicine. | Daisley BA, Allen-Vercoe E. | Ann N Y Acad Sci | 10.1111/nyas.15237 | 2024 | ||
| Proof of Concept of Culturomics Use of Time of Care. | Naud S, Khelaifia S, Mbogning Fonkou MD, Dione N, Lagier JC, Raoult D. | Front Cell Infect Microbiol | 10.3389/fcimb.2020.524769 | 2020 | ||
| Genetics | Completion of draft bacterial genomes by long-read sequencing of synthetic genomic pools. | Derakhshani H, Bernier SP, Marko VA, Surette MG. | BMC Genomics | 10.1186/s12864-020-06910-6 | 2020 | |
| Beneficial Bacteria Isolated from Food in Relation to the Next Generation of Probiotics. | Sionek B, Szydlowska A, Zielinska D, Neffe-Skocinska K, Kolozyn-Krajewska D. | Microorganisms | 10.3390/microorganisms11071714 | 2023 | ||
| Possible role of the gut microbiota in the pathogenesis of anorexia nervosa. | Sudo N. | Biopsychosoc Med | 10.1186/s13030-021-00228-9 | 2021 | ||
| Pathogenicity | Impact of dietary resistant starch type 4 on human gut microbiota and immunometabolic functions. | Upadhyaya B, McCormack L, Fardin-Kia AR, Juenemann R, Nichenametla S, Clapper J, Specker B, Dey M. | Sci Rep | 10.1038/srep28797 | 2016 | |
| Gut microbiome and Mediterranean diet in the context of obesity. Current knowledge, perspectives and potential therapeutic targets. | Tsigalou C, Paraschaki A, Karvelas A, Kantartzi K, Gagali K, Tsairidis D, Bezirtzoglou E. | Metabol Open | 10.1016/j.metop.2021.100081 | 2021 | ||
| Characterization of Two Parabacteroides distasonis Candidate Strains as New Live Biotherapeutics against Obesity. | Cuffaro B, Boutillier D, Desramaut J, Jablaoui A, Werkmeister E, Trottein F, Waligora-Dupriet AJ, Rhimi M, Maguin E, Grangette C. | Cells | 10.3390/cells12091260 | 2023 | ||
| Insect-based diet, a promising nutritional source, modulates gut microbiota composition and SCFAs production in laying hens. | Borrelli L, Coretti L, Dipineto L, Bovera F, Menna F, Chiariotti L, Nizza A, Lembo F, Fioretti A. | Sci Rep | 10.1038/s41598-017-16560-6 | 2017 | ||
| Alteration of gut microbiota in wild-borne long-tailed macaques after 1-year being housed in hygienic captivity. | Sawaswong V, Chanchaem P, Kemthong T, Warit S, Chaiprasert A, Malaivijitnond S, Payungporn S. | Sci Rep | 10.1038/s41598-023-33163-6 | 2023 | ||
| Pathogenicity | ADS024, a single-strain live biotherapeutic product of Bacillus velezensis alleviates dextran sulfate-mediated colitis in mice, protects human colonic epithelial cells against apoptosis, and maintains epithelial barrier function | Irwin S, Chupina Estrada A, Nelson B, Bullock A, Limketkai B, Ho W, Acton S, Chesnel L, Koon H. | Front Microbiol | 2023 | ||
| Understanding dysbiosis and resilience in the human gut microbiome: biomarkers, interventions, and challenges. | Safarchi A, Al-Qadami G, Tran CD, Conlon M. | Front Microbiol | 10.3389/fmicb.2025.1559521 | 2025 | ||
| Pathogenicity | Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease. | Onate FP, Chamignon C, Burz SD, Lapaque N, Monnoye M, Philippe C, Bredel M, Chene L, Farin W, Paillarse JM, Boursier J, Ratziu V, Mousset PY, Dore J, Gerard P, Blottiere HM. | Int J Mol Sci | 10.3390/ijms241512232 | 2023 | |
| Next generation probiotics in disease amelioration. | Chang CJ, Lin TL, Tsai YL, Wu TR, Lai WF, Lu CC, Lai HC. | J Food Drug Anal | 10.1016/j.jfda.2018.12.011 | 2019 | ||
| Host genes and their effect on the intestinal microbiome garden. | Jacobs J, Braun J. | Genome Med | 10.1186/s13073-014-0119-x | 2014 | ||
| Methanobrevibacter smithii cell variants in human physiology and pathology: A review. | Malat I, Drancourt M, Grine G. | Heliyon | 10.1016/j.heliyon.2024.e36742 | 2024 | ||
| Methanogenic patterns in the gut microbiome are associated with survival in a population of feral horses. | Stothart MR, McLoughlin PD, Medill SA, Greuel RJ, Wilson AJ, Poissant J. | Nat Commun | 10.1038/s41467-024-49963-x | 2024 | ||
| Genetics | Host diet shapes functionally differentiated gut microbiomes in sympatric speciation of blind mole rats in Upper Galilee, Israel. | Kuang Z, Li F, Duan Q, Tian C, Nevo E, Li K. | Front Microbiol | 10.3389/fmicb.2022.1062763 | 2022 | |
| Integrative metagenomic and metabolomic analyses reveal the potential of gut microbiota to exacerbate acute pancreatitis. | Liu J, Yan Q, Li S, Jiao J, Hao Y, Zhang G, Zhang Q, Luo F, Zhang Y, Lv Q, Zhang W, Zhang A, Song H, Xin Y, Ma Y, Owusu L, Ma X, Yin P, Shang D. | NPJ Biofilms Microbiomes | 10.1038/s41522-024-00499-4 | 2024 | ||
| Ethnic variations in metabolic syndrome components and their associations with the gut microbiota: the HELIUS study. | Balvers M, de Goffau M, van Riel N, van den Born BJ, Galenkamp H, Zwinderman K, Nieuwdorp M, Levin E. | Genome Med | 10.1186/s13073-024-01295-7 | 2024 | ||
| Pathogenicity | Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial. | Zhang X, Irajizad E, Hoffman KL, Fahrmann JF, Li F, Seo YD, Browman GJ, Dennison JB, Vykoukal J, Luna PN, Siu W, Wu R, Murage E, Ajami NJ, McQuade JL, Wargo JA, Long JP, Do KA, Lampe JW, Basen-Engquist KM, Okhuysen PC, Kopetz S, Hanash SM, Petrosino JF, Scheet P, Daniel CR. | EBioMedicine | 10.1016/j.ebiom.2023.104873 | 2023 | |
| Next generation probiotics for human health: An emerging perspective. | Jan T, Negi R, Sharma B, Kumar S, Singh S, Rai AK, Shreaz S, Rustagi S, Chaudhary N, Kaur T, Kour D, Sheikh MA, Kumar K, Yadav AN, Ahmed N. | Heliyon | 10.1016/j.heliyon.2024.e35980 | 2024 | ||
| Genetics | Changes in Gut Microbiota of Patients with Atopic Dermatitis During Balneotherapy. | Thirion F, Guilly S, Fromentin S, Plaza Onate F, Alvarez AS, Le Chatelier E, Pons N, Levenez F, Quinquis B, Ehrlich S, Dore J, Martin R, Seite S. | Clin Cosmet Investig Dermatol | 10.2147/ccid.s342104 | 2022 | |
| B. vulgatus ameliorates high-fat diet-induced obesity through modulating intestinal serotonin synthesis and lipid absorption in mice. | Wen X, Feng X, Xin F, An R, Huang H, Mao L, Liu P, Zhang J, Huang H, Liu X, Wang W. | Gut Microbes | 10.1080/19490976.2024.2423040 | 2024 | ||
| Networks of gut bacteria relate to cardiovascular disease in a multi-ethnic population: the HELIUS study. | Warmbrunn MV, Boulund U, Aron-Wisnewsky J, de Goffau MC, Abeka RE, Davids M, Bresser LRF, Levin E, Clement K, Galenkamp H, Ferwerda B, van den Born BJH, Kurilshikov A, Fu J, Zwinderman AH, Soeters MR, van Raalte DH, Herrema H, Groen AK, Nieuwdorp M. | Cardiovasc Res | 10.1093/cvr/cvae018 | 2024 | ||
| Gut bacterial profiles in Parkinson's disease: A systematic review. | Li Z, Liang H, Hu Y, Lu L, Zheng C, Fan Y, Wu B, Zou T, Luo X, Zhang X, Zeng Y, Liu Z, Zhou Z, Yue Z, Ren Y, Li Z, Su Q, Xu P. | CNS Neurosci Ther | 10.1111/cns.13990 | 2023 | ||
| Fecal microbiota profiles of growing pigs and their relation to growth performance. | Konig E, Beasley S, Heponiemi P, Kivinen S, Rakkolainen J, Salminen S, Collado MC, Borman T, Lahti L, Piirainen V, Valros A, Heinonen M. | PLoS One | 10.1371/journal.pone.0302724 | 2024 | ||
| Genetics | Variations in the Relative Abundance of Gut Bacteria Correlate with Lipid Profiles in Healthy Adults. | Kalnina I, Gudra D, Silamikelis I, Viksne K, Roga A, Skinderskis E, Fridmanis D, Klovins J. | Microorganisms | 10.3390/microorganisms11112656 | 2023 | |
| Phylogeny | Fine-scale spatial variation shape fecal microbiome diversity and composition in black-tailed prairie dogs (Cynomys ludovicianus). | Neha SA, Salazar-Bravo J. | BMC Microbiol | 10.1186/s12866-023-02778-0 | 2023 | |
| Phylogeny | Luminal and mucosa-associated caecal microbiota of chickens after experimental Campylobacter jejuni infection in the absence of Campylobacter-specific phages of group II and III. | Hankel J, Kittler S, Chuppava B, Galvez E, Strowig T, Becker A, von Kockritz-Blickwede M, Plotz M, Visscher C. | Microb Genom | 10.1099/mgen.0.000874 | 2022 | |
| Pathogenicity | DMARDs-Gut Microbiota Feedback: Implications in the Response to Therapy. | Zaragoza-Garcia O, Castro-Alarcon N, Perez-Rubio G, Guzman-Guzman IP. | Biomolecules | 10.3390/biom10111479 | 2020 | |
| Cross-feeding in the gut microbiome: Ecology and mechanisms. | Culp EJ, Goodman AL. | Cell Host Microbe | 10.1016/j.chom.2023.03.016 | 2023 | ||
| Probiotic and postbiotic analytical methods: a perspective of available enumeration techniques. | Boyte ME, Benkowski A, Pane M, Shehata HR. | Front Microbiol | 10.3389/fmicb.2023.1304621 | 2023 | ||
| Association of the Gut Microbiota with Weight-Loss Response within a Retail Weight-Management Program. | Dhakal S, McCormack L, Dey M. | Microorganisms | 10.3390/microorganisms8081246 | 2020 | ||
| How does age determine the development of human immune-mediated arthritis? | Degboe Y, Vastert SJ, Prakken BJ, McInnes IB. | Nat Rev Rheumatol | 10.1038/s41584-022-00814-3 | 2022 | ||
| Phylogeny | Human genetics shape the gut microbiome. | Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, Beaumont M, Van Treuren W, Knight R, Bell JT, Spector TD, Clark AG, Ley RE. | Cell | 10.1016/j.cell.2014.09.053 | 2014 | |
| Preliminary evidence for an influence of exposure to polycyclic aromatic hydrocarbons on the composition of the gut microbiota and neurodevelopment in three-year-old healthy children. | Zhang W, Sun Z, Zhang Q, Sun Z, Su Y, Song J, Wang B, Gao R. | BMC Pediatr | 10.1186/s12887-021-02539-w | 2021 | ||
| Rumen Epithelial Communities Share a Core Bacterial Microbiota: A Meta-Analysis of 16S rRNA Gene Illumina MiSeq Sequencing Datasets. | Anderson CJ, Koester LR, Schmitz-Esser S. | Front Microbiol | 10.3389/fmicb.2021.625400 | 2021 | ||
| Metabolism | From correlation to causality: the case of Subdoligranulum. | Van Hul M, Le Roy T, Prifti E, Dao MC, Paquot A, Zucker JD, Delzenne NM, Muccioli G, Clement K, Cani PD. | Gut Microbes | 10.1080/19490976.2020.1849998 | 2020 | |
| A Cross-Scale Neutral Theory Approach to the Influence of Obesity on Community Assembly of Human Gut Microbiome. | Li W, Yuan Y, Xia Y, Sun Y, Miao Y, Ma S. | Front Microbiol | 10.3389/fmicb.2018.02320 | 2018 | ||
| Pathogenicity | Proteobacteria Overgrowth and Butyrate-Producing Taxa Depletion in the Gut Microbiota of Glycogen Storage Disease Type 1 Patients. | Ceccarani C, Bassanini G, Montanari C, Casiraghi MC, Ottaviano E, Morace G, Biasucci G, Paci S, Borghi E, Verduci E. | Metabolites | 10.3390/metabo10040133 | 2020 | |
| Light-Stress Influences the Composition of the Murine Gut Microbiome, Memory Function, and Plasma Metabolome. | Kim YM, Snijders AM, Brislawn CJ, Stratton KG, Zink EM, Fansler SJ, Metz TO, Mao JH, Jansson JK. | Front Mol Biosci | 10.3389/fmolb.2019.00108 | 2019 | ||
| Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives. | Abouelela ME, Helmy YA. | Microorganisms | 10.3390/microorganisms12030430 | 2024 | ||
| Combined Toxicity Evaluation of Ochratoxin A and Aflatoxin B1 on Kidney and Liver Injury, Immune Inflammation, and Gut Microbiota Alteration Through Pair-Feeding Pullet Model. | Qing H, Huang S, Zhan K, Zhao L, Zhang J, Ji C, Ma Q. | Front Immunol | 10.3389/fimmu.2022.920147 | 2022 | ||
| Metabolism | Next Generation Microbiome Research: Identification of Keystone Species in the Metabolic Regulation of Host-Gut Microbiota Interplay. | Tudela H, Claus SP, Saleh M. | Front Cell Dev Biol | 10.3389/fcell.2021.719072 | 2021 | |
| Phylogeny | Re-initiation of Oral Food Intake Following Enteral Nutrition Alters Oral and Gut Microbiota Communities. | Katagiri S, Shiba T, Tohara H, Yamaguchi K, Hara K, Nakagawa K, Komatsu K, Watanabe K, Ohsugi Y, Maekawa S, Iwata T. | Front Cell Infect Microbiol | 10.3389/fcimb.2019.00434 | 2019 | |
| The Immune Barrier of Porcine Uterine Mucosa Differs Dramatically at Proliferative and Secretory Phases and Could Be Positively Modulated by Colonizing Microbiota. | Han D, Sun P, Hu Y, Wang J, Hua G, Chen J, Shao C, Tian F, Darwish HYA, Tai Y, Yang X, Chang J, Ma Y. | Front Immunol | 10.3389/fimmu.2021.750808 | 2021 | ||
| Genetics | A network approach to investigating the key microbes and stability of gut microbial communities in a mouse neuropathic pain model. | Brandon-Mong GJ, Shaw GT, Chen WH, Chen CC, Wang D. | BMC Microbiol | 10.1186/s12866-020-01981-7 | 2020 | |
| Clinically Effective Molecules of Natural Origin for Obesity Prevention or Treatment. | Hidalgo-Lozada GM, Villarruel-Lopez A, Nuno K, Garcia-Garcia A, Sanchez-Nuno YA, Ramos-Garcia CO. | Int J Mol Sci | 10.3390/ijms25052671 | 2024 | ||
| Investigating the Mechanistic Differences of Obesity-Inducing Lactobacillus kefiranofaciens M1 and Anti-obesity Lactobacillus mali APS1 by Microbolomics and Metabolomics. | Lin YC, Chen YT, Li KY, Chen MJ. | Front Microbiol | 10.3389/fmicb.2020.01454 | 2020 | ||
| Metabolism | Depletion of microbiome-derived molecules in the host using Clostridium genetics. | Guo CJ, Allen BM, Hiam KJ, Dodd D, Van Treuren W, Higginbottom S, Nagashima K, Fischer CR, Sonnenburg JL, Spitzer MH, Fischbach MA. | Science | 10.1126/science.aav1282 | 2019 | |
| Pathogenicity | B Cells and Microbiota in Autoimmunity. | Botia-Sanchez M, Alarcon-Riquelme ME, Galicia G. | Int J Mol Sci | 10.3390/ijms22094846 | 2021 | |
| Gut microbiota-derived metabolites in obesity: a systematic review. | Ejtahed HS, Angoorani P, Soroush AR, Hasani-Ranjbar S, Siadat SD, Larijani B. | Biosci Microbiota Food Health | 10.12938/bmfh.2019-026 | 2020 | ||
| Pathogenicity | Physical fitness in community-dwelling older adults is linked to dietary intake, gut microbiota, and metabolomic signatures. | Castro-Mejia JL, Khakimov B, Krych L, Bulow J, Bechshoft RL, Hojfeldt G, Mertz KH, Garne ES, Schacht SR, Ahmad HF, Kot W, Hansen LH, Perez-Cueto FJA, Lind MV, Lassen AJ, Tetens I, Jensen T, Reitelseder S, Jespersen AP, Holm L, Engelsen SB, Nielsen DS. | Aging Cell | 10.1111/acel.13105 | 2020 | |
| Metabolism | Gut Microbiota Serves a Predictable Outcome of Short-Term Low-Carbohydrate Diet (LCD) Intervention for Patients with Obesity. | Zhang S, Wu P, Tian Y, Liu B, Huang L, Liu Z, Lin N, Xu N, Ruan Y, Zhang Z, Wang M, Cui Z, Zhou H, Xie L, Chen H, Sun J. | Microbiol Spectr | 10.1128/spectrum.00223-21 | 2021 | |
| Genetics | Reduced B12 uptake and increased gastrointestinal formate are associated with archaeome-mediated breath methane emission in humans. | Kumpitsch C, Fischmeister FPS, Mahnert A, Lackner S, Wilding M, Sturm C, Springer A, Madl T, Holasek S, Hogenauer C, Berg IA, Schoepf V, Moissl-Eichinger C. | Microbiome | 10.1186/s40168-021-01130-w | 2021 | |
| Enzymology | Intestinal Morphometry, Enzymatic and Microbial Activity in Laying Hens Fed Different Levels of a Hermetia illucens Larvae Meal and Toxic Elements Content of the Insect Meal and Diets. | Moniello G, Ariano A, Panettieri V, Tulli F, Olivotto I, Messina M, Randazzo B, Severino L, Piccolo G, Musco N, Addeo NF, Hassoun G, Bovera F. | Animals (Basel) | 10.3390/ani9030086 | 2019 | |
| Pathogenicity | Gut microbiota and butyrate level changes associated with the long-term administration of proton pump inhibitors to old rats. | Lee SM, Kim N, Nam RH, Park JH, Choi SI, Park YT, Kim YR, Seok YJ, Shin CM, Lee DH. | Sci Rep | 10.1038/s41598-019-43112-x | 2019 | |
| Metabolism | Resistant starch, microbiome, and precision modulation. | Dobranowski PA, Stintzi A. | Gut Microbes | 10.1080/19490976.2021.1926842 | 2021 | |
| Phylogeny | Precise Fecal Microbiome of the Herbivorous Tibetan Antelope Inhabiting High-Altitude Alpine Plateau. | Bai X, Lu S, Yang J, Jin D, Pu J, Diaz Moya S, Xiong Y, Rossello-Mora R, Xu J. | Front Microbiol | 10.3389/fmicb.2018.02321 | 2018 | |
| Phylogeny | Dynamics of Gut Microbiota and Clinical Variables after Ketogenic and Mediterranean Diets in Drug-Naïve Patients with Type 2 Diabetes Mellitus and Obesity. | Deledda A, Palmas V, Heidrich V, Fosci M, Lombardo M, Cambarau G, Lai A, Melis M, Loi E, Loviselli A, Manzin A, Velluzzi F. | Metabolites | 10.3390/metabo12111092 | 2022 | |
| Gut microbiota phenotypes of obesity. | Stanislawski MA, Dabelea D, Lange LA, Wagner BD, Lozupone CA. | NPJ Biofilms Microbiomes | 10.1038/s41522-019-0091-8 | 2019 | ||
| Shifts on Gut Microbiota Associated to Mediterranean Diet Adherence and Specific Dietary Intakes on General Adult Population. | Garcia-Mantrana I, Selma-Royo M, Alcantara C, Collado MC. | Front Microbiol | 10.3389/fmicb.2018.00890 | 2018 | ||
| Lack of Adrenomedullin Results in Microbiota Changes and Aggravates Azoxymethane and Dextran Sulfate Sodium-Induced Colitis in Mice. | Martinez-Herrero S, Larrayoz IM, Narro-Iniguez J, Villanueva-Millan MJ, Recio-Fernandez E, Perez-Matute P, Oteo JA, Martinez A. | Front Physiol | 10.3389/fphys.2016.00595 | 2016 | ||
| Phylogeny | Strategies for the Identification and Assessment of Bacterial Strains with Specific Probiotic Traits. | Torres-Maravilla E, Reyes-Pavon D, Benitez-Cabello A, Gonzalez-Vazquez R, Ramirez-Chamorro LM, Langella P, Bermudez-Humaran LG. | Microorganisms | 10.3390/microorganisms10071389 | 2022 | |
| Human gut microbiome: hopes, threats and promises. | Cani PD. | Gut | 10.1136/gutjnl-2018-316723 | 2018 | ||
| The Consumption of Bicarbonate-Rich Mineral Water Improves Glycemic Control. | Murakami S, Goto Y, Ito K, Hayasaka S, Kurihara S, Soga T, Tomita M, Fukuda S. | Evid Based Complement Alternat Med | 10.1155/2015/824395 | 2015 | ||
| Research Advances of d-allulose: An Overview of Physiological Functions, Enzymatic Biotransformation Technologies, and Production Processes. | Xia Y, Cheng Q, Mu W, Hu X, Sun Z, Qiu Y, Liu X, Wang Z. | Foods | 10.3390/foods10092186 | 2021 | ||
| Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases. | Mutalub YB, Abdulwahab M, Mohammed A, Yahkub AM, Al-Mhanna SB, Yusof W, Tang SP, Rasool AHG, Mokhtar SS. | Foods | 10.3390/foods11172575 | 2022 | ||
| Metabolism | Microbiota and body weight control: Weight watchers within? | Boscaini S, Leigh SJ, Lavelle A, Garcia-Cabrerizo R, Lipuma T, Clarke G, Schellekens H, Cryan JF. | Mol Metab | 10.1016/j.molmet.2021.101427 | 2022 | |
| A taxonomic signature of obesity in a large study of American adults. | Peters BA, Shapiro JA, Church TR, Miller G, Trinh-Shevrin C, Yuen E, Friedlander C, Hayes RB, Ahn J. | Sci Rep | 10.1038/s41598-018-28126-1 | 2018 | ||
| Genetics | Enabling rational gut microbiome manipulations by understanding gut ecology through experimentally-evidenced in silico models. | Molina Ortiz JP, McClure DD, Shanahan ER, Dehghani F, Holmes AJ, Read MN. | Gut Microbes | 10.1080/19490976.2021.1965698 | 2021 | |
| Over-feeding the gut microbiome: A scoping review on health implications and therapeutic perspectives. | Barone M, D'Amico F, Fabbrini M, Rampelli S, Brigidi P, Turroni S. | World J Gastroenterol | 10.3748/wjg.v27.i41.7041 | 2021 | ||
| Multi-omics Analysis Revealed Coordinated Responses of Rumen Microbiome and Epithelium to High-Grain-Induced Subacute Rumen Acidosis in Lactating Dairy Cows. | Mu Y, Qi W, Zhang T, Zhang J, Mao S. | mSystems | 10.1128/msystems.01490-21 | 2022 | ||
| Genetic Determinants of the Gut Microbiome in UK Twins. | Goodrich JK, Davenport ER, Beaumont M, Jackson MA, Knight R, Ober C, Spector TD, Bell JT, Clark AG, Ley RE. | Cell Host Microbe | 10.1016/j.chom.2016.04.017 | 2016 | ||
| Metabolism | Bacteroides uniformis CECT 7771 Modulates the Brain Reward Response to Reduce Binge Eating and Anxiety-Like Behavior in Rat. | Agusti A, Campillo I, Balzano T, Benitez-Paez A, Lopez-Almela I, Romani-Perez M, Forteza J, Felipo V, Avena NM, Sanz Y. | Mol Neurobiol | 10.1007/s12035-021-02462-2 | 2021 | |
| Gut Dysbiosis in Patients with Anorexia Nervosa. | Morita C, Tsuji H, Hata T, Gondo M, Takakura S, Kawai K, Yoshihara K, Ogata K, Nomoto K, Miyazaki K, Sudo N. | PLoS One | 10.1371/journal.pone.0145274 | 2015 | ||
| Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases. | Gerhardt S, Mohajeri MH. | Nutrients | 10.3390/nu10060708 | 2018 | ||
| Gut Microbiota in Cardiovascular Health and Disease. | Tang WH, Kitai T, Hazen SL. | Circ Res | 10.1161/circresaha.117.309715 | 2017 | ||
| Phylogeny | Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection. | Montassier E, Al-Ghalith GA, Ward T, Corvec S, Gastinne T, Potel G, Moreau P, de la Cochetiere MF, Batard E, Knights D. | Genome Med | 10.1186/s13073-016-0301-4 | 2016 | |
| Genetics | A review of 10 years of human microbiome research activities at the US National Institutes of Health, Fiscal Years 2007-2016. | NIH Human Microbiome Portfolio Analysis Team. | Microbiome | 10.1186/s40168-019-0620-y | 2019 | |
| Enlightening the taxonomy darkness of human gut microbiomes with a cultured biobank. | Liu C, Du MX, Abuduaini R, Yu HY, Li DH, Wang YJ, Zhou N, Jiang MZ, Niu PX, Han SS, Chen HH, Shi WY, Wu L, Xin YH, Ma J, Zhou Y, Jiang CY, Liu HW, Liu SJ. | Microbiome | 10.1186/s40168-021-01064-3 | 2021 | ||
| Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. | Flynn CR, Albaugh VL, Cai S, Cheung-Flynn J, Williams PE, Brucker RM, Bordenstein SR, Guo Y, Wasserman DH, Abumrad NN. | Nat Commun | 10.1038/ncomms8715 | 2015 | ||
| Enzymology | State of the Art in the Culture of the Human Microbiota: New Interests and Strategies. | Tidjani Alou M, Naud S, Khelaifia S, Bonnet M, Lagier JC, Raoult D. | Clin Microbiol Rev | 10.1128/cmr.00129-19 | 2020 | |
| Metabolism | Links between Dietary Protein Sources, the Gut Microbiota, and Obesity. | Madsen L, Myrmel LS, Fjaere E, Liaset B, Kristiansen K. | Front Physiol | 10.3389/fphys.2017.01047 | 2017 | |
| Metabolism | Impact of short-chain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals. | Azcarate-Peril MA, Ritter AJ, Savaiano D, Monteagudo-Mera A, Anderson C, Magness ST, Klaenhammer TR. | Proc Natl Acad Sci U S A | 10.1073/pnas.1606722113 | 2017 | |
| Cultivation and sequencing of rumen microbiome members from the Hungate1000 Collection. | Seshadri R, Leahy SC, Attwood GT, Teh KH, Lambie SC, Cookson AL, Eloe-Fadrosh EA, Pavlopoulos GA, Hadjithomas M, Varghese NJ, Paez-Espino D, Hungate1000 project collaborators, Perry R, Henderson G, Creevey CJ, Terrapon N, Lapebie P, Drula E, Lombard V, Rubin E, Kyrpides NC, Henrissat B, Woyke T, Ivanova NN, Kelly WJ. | Nat Biotechnol | 10.1038/nbt.4110 | 2018 | ||
| Metabolism | Repeated inoculation of cattle rumen with bison rumen contents alters the rumen microbiome and improves nitrogen digestibility in cattle. | Ribeiro GO, Oss DB, He Z, Gruninger RJ, Elekwachi C, Forster RJ, Yang W, Beauchemin KA, McAllister TA. | Sci Rep | 10.1038/s41598-017-01269-3 | 2017 | |
| Phylogeny | The gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolism. | Just S, Mondot S, Ecker J, Wegner K, Rath E, Gau L, Streidl T, Hery-Arnaud G, Schmidt S, Lesker TR, Bieth V, Dunkel A, Strowig T, Hofmann T, Haller D, Liebisch G, Gerard P, Rohn S, Lepage P, Clavel T. | Microbiome | 10.1186/s40168-018-0510-8 | 2018 | |
| Enzymology | Exposure to household furry pets influences the gut microbiota of infant at 3-4 months following various birth scenarios. | Tun HM, Konya T, Takaro TK, Brook JR, Chari R, Field CJ, Guttman DS, Becker AB, Mandhane PJ, Turvey SE, Subbarao P, Sears MR, Scott JA, Kozyrskyj AL, CHILD Study Investigators. | Microbiome | 10.1186/s40168-017-0254-x | 2017 | |
| Phylogeny | Phylosymbiosis: Relationships and Functional Effects of Microbial Communities across Host Evolutionary History. | Brooks AW, Kohl KD, Brucker RM, van Opstal EJ, Bordenstein SR. | PLoS Biol | 10.1371/journal.pbio.2000225 | 2016 | |
| Metabolism | Diet-microbiota interactions as moderators of human metabolism. | Sonnenburg JL, Backhed F. | Nature | 10.1038/nature18846 | 2016 | |
| The first 1000 cultured species of the human gastrointestinal microbiota. | Rajilic-Stojanovic M, de Vos WM. | FEMS Microbiol Rev | 10.1111/1574-6976.12075 | 2014 | ||
| Cultivation | Species-targeted sorting and cultivation of commensal bacteria from the gut microbiome using flow cytometry under anaerobic conditions. | Bellais S, Nehlich M, Ania M, Duquenoy A, Mazier W, van den Engh G, Baijer J, Treichel NS, Clavel T, Belotserkovsky I, Thomas V | Microbiome | 10.1186/s40168-021-01206-7 | 2022 | |
| Pathogenicity | Gilbert's Syndrome and the Gut Microbiota - Insights From the Case-Control BILIHEALTH Study. | Zohrer PA, Hana CA, Seyed Khoei N, Molzer C, Hormann-Wallner M, Tosevska A, Doberer D, Marculescu R, Bulmer AC, Herbold CW, Berry D, Wagner KH | Front Cell Infect Microbiol | 10.3389/fcimb.2021.701109 | 2021 | |
| Pathogenicity | The Keystone commensal bacterium Christensenella minuta DSM 22607 displays anti-inflammatory properties both in vitro and in vivo. | Kropp C, Le Corf K, Relizani K, Tambosco K, Martinez C, Chain F, Rawadi G, Langella P, Claus SP, Martin R | Sci Rep | 10.1038/s41598-021-90885-1 | 2021 | |
| Draft Genome Analysis of Christensenella minuta DSM 22607, exhibiting an unusual expansion of transporter homologs of unknown function. | Coil DA, Jospin G, Eisen JA | J Genomics | 10.7150/jgen.43162 | 2020 | ||
| Genetics | Genome Sequence of Christensenella minuta DSM 22607T. | Rosa BA, Hallsworth-Pepin K, Martin J, Wollam A, Mitreva M | Genome Announc | 10.1128/genomeA.01451-16 | 2017 | |
| Christensenella regulated by Huang-Qi-Ling-Hua-San is a key factor by which to improve type 2 diabetes. | Pan T, Zheng S, Zheng W, Shi C, Ning K, Zhang Q, Xie Y, Xiang H, Xie Q | Front Microbiol | 10.3389/fmicb.2022.1022403 | 2022 | ||
| Genetics | Maliibacterium massiliense gen. nov. sp. nov., Isolated from Human Feces and Proposal of Maliibacteriaceae fam. nov. | Traore SI, Lo CI, Mossaab M, Durand G, Lagier JC, Raoult D, Fournier PE, Fenollar F. | Curr Microbiol | 10.1007/s00284-023-03301-4 | 2023 | |
| Metabolism | Description of Christensenella minuta gen. nov., sp. nov., isolated from human faeces, which forms a distinct branch in the order Clostridiales, and proposal of Christensenellaceae fam. nov. | Morotomi M, Nagai F, Watanabe Y | Int J Syst Evol Microbiol | 10.1099/ijs.0.026989-0 | 2011 | |
| Phylogeny | Taxonomic Description and Genome Sequence of Christensenella intestinihominis sp. nov., a Novel Cholesterol-Lowering Bacterium Isolated From Human Gut. | Zou Y, Xue W, Lin X, Hu T, Liu SW, Sun CH, Luo G, Lv M, Dai Y, Kristiansen K, Xiao L | Front Microbiol | 10.3389/fmicb.2021.632361 | 2021 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #21228 | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 22607 |
| #26303 | IJSEM 144 2012 ( DOI 10.1099/ijs.0.026989-0 , PubMed 21357455 ) |
| #29932 | Barberan A, Caceres Velazquez H, Jones S, Fierer N.: Hiding in Plain Sight: Mining Bacterial Species Records for Phenotypic Trait Information. mSphere 2: 2017 ( DOI 10.1128/mSphere.00237-17 , PubMed 28776041 ) - originally annotated from #26303 |
| #66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) . |
| #66794 | Antje Chang, Lisa Jeske, Sandra Ulbrich, Julia Hofmann, Julia Koblitz, Ida Schomburg, Meina Neumann-Schaal, Dieter Jahn, Dietmar Schomburg: BRENDA, the ELIXIR core data resource in 2021: new developments and updates. Nucleic Acids Res. 49: D498 - D508 2020 ( DOI 10.1093/nar/gkaa1025 , PubMed 33211880 ) |
| #67770 | Japan Collection of Microorganism (JCM) ; Curators of the JCM; |
| #69479 | João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta . |
| #125438 | Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann: Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets. 2024 ( DOI 10.1101/2024.08.12.607695 ) |
| #125439 | Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardy: deepG: Deep Learning for Genome Sequence Data. R package version 0.3.1 . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive24747.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data